Amneal Pharmaceuticals, Inc.
AMRX
Cena:
Valuace
0
Růst
40
Zdraví
47
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
AMNEAL PHARMACEUTICALS ADDED TO S&P SMALLCAP 600® INDEX
28-01-2026
BRIDGEWATER, N.J., JAN. 28, 2026 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (...
Více zde
TTM TECHNOLOGIES, DUTCH BROS, ADVANCED ENERGY INDUSTRIES, AND AMERICAN HEALTHCARE REIT SET TO JOIN S&P MIDCAP 400; OTHERS TO JOIN S&P SMALLCAP 600
27-01-2026
NEW YORK, JAN. 27, 2026 /PRNEWSWIRE/ -- S&P DOW JONES INDICES WILL MAKE THE FOLLOWING CHANGES TO TH...
Více zde
AMNEAL TO REPORT FOURTH QUARTER AND FULL YEAR 2025 RESULTS ON FEBRUARY 27, 2026
27-01-2026
BRIDGEWATER, N.J., JAN. 27, 2026 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (...
Více zde
KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON'S DISEASE
09-01-2026
WASHINGTON--(BUSINESS WIRE)--KEIFERX, A PRIVATELY HELD BIOTECHNOLOGY COMPANY DEVELOPING DISEASE-MODI...
Více zde
AMNEAL ANNOUNCES FDA APPROVAL OF DENOSUMAB BIOSIMILARS REFERENCING PROLIA® AND XGEVA®
22-12-2025
BRIDGEWATER, N.J., DEC. 22, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR EPINEPHRINE INJECTION IN SINGLE- AND MULTI-DOSE VIALS FOR U.S. HOSPITALS
09-12-2025
BRIDGEWATER, N.J., DEC. 09, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL ANNOUNCES POSITIVE INTERIM PHASE 4 ELEVATE-PD RESULTS WITH CREXONT® FOR PARKINSON'S DISEASE
05-12-2025
BRIDGEWATER, N.J., DEC. 05, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
02-12-2025
BRIDGEWATER, N.J., DEC. 02, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) TOD...
Více zde
AMNEAL ANNOUNCES U.S. FDA APPROVAL OF CYCLOSPORINE OPHTHALMIC EMULSION 0.05%
01-12-2025
APPROVAL UNDERSCORES AMNEAL'S ADVANCED STERILE MANUFACTURING CAPABILITIES AND EXPANSION WITHIN COMPL...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR IOHEXOL INJECTION
13-11-2025
BRIDGEWATER, N.J., NOV. 13, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
30-10-2025
‒ Q3 2025 NET REVENUE OF $785 MILLION ; GAAP NET INCOME OF $2 MILLION ; DILUTED INCOME PER SHARE O...
Více zde
AMNEAL RECEIVES U.S. FDA TENTATIVE APPROVAL FOR BECLOMETHASONE DIPROPIONATE HFA INHALATION AEROSOL
29-10-2025
BRIDGEWATER, N.J., OCT. 29, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL LAUNCHES BREKIYA® – THE FIRST AND ONLY DHE AUTOINJECTOR FOR ADULTS WITH MIGRAINE WITH OR WITHOUT AURA AND CLUSTER HEADACHES
27-10-2025
BRIDGEWATER, N.J., OCT. 27, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (...
Více zde
AMNEAL TO REPORT THIRD QUARTER 2025 RESULTS ON OCTOBER 30, 2025
30-09-2025
BRIDGEWATER, N.J., SEPT. 30, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (...
Více zde
AMNEAL ANNOUNCES BLA SUBMISSION OF BIOSIMILAR CANDIDATE TO XOLAIR® (OMALIZUMAB)
26-09-2025
POTENTIAL FIRST-WAVE ENTRY INTO THE $4+ BILLION U.S. MARKET AND AN IMPORTANT NEW GROWTH DRIVER FOR A...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR BIMATOPROST OPHTHALMIC SOLUTION, 0.01%
23-09-2025
BRIDGEWATER, N.J., SEPT. 23, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR ...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL OF SODIUM OXYBATE ORAL SOLUTION
11-09-2025
BRIDGEWATER, N.J, SEPT. 11, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR RISPERIDONE EXTENDED-RELEASE INJECTABLE SUSPENSION
04-09-2025
BRIDGEWATER, N.J., SEPT. 04, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR ...
Více zde
KNIGHT THERAPEUTICS ANNOUNCES REGULATORY SUBMISSION OF CREXONT® (CARBIDOPA AND LEVODOPA) EXTENDED-RELEASE CAPSULES IN MEXICO
05-08-2025
MONTREAL, AUG. 05, 2025 (GLOBE NEWSWIRE) -- KNIGHT THERAPEUTICS INC., (TSX: GUD) ("KNIGHT") A PAN-AM...
Více zde
AMNEAL REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
05-08-2025
‒ Q2 2025 NET REVENUE OF $725 MILLION ; GAAP NET INCOME OF $22 MILLION ; DILUTED INCOME PER SHARE ...
Více zde
AMNEAL ANNOUNCES PROPOSED REFINANCING OF EXISTING CREDIT AGREEMENT, INCLUDING PRIVATE OFFERING OF SENIOR SECURED NOTES DUE 2032
21-07-2025
BRIDGEWATER, N.J., JULY 21, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL”) (NA...
Více zde
AMNEAL REPORTS CERTAIN PRELIMINARY SECOND QUARTER 2025 FINANCIAL RESULTS
21-07-2025
– RESULTS REFLECT CONTINUED FINANCIAL STRENGTH AND DELEVERAGING – BRIDGEWATER, N.J., JULY 21, 20...
Více zde
KNIGHT THERAPEUTICS ANNOUNCES FILING OF NEW DRUG SUBMISSION FOR CREXONT® (CARBIDOPA AND LEVODOPA) EXTENDED-RELEASE CAPSULES IN CANADA
18-07-2025
MONTREAL, JULY 18, 2025 (GLOBE NEWSWIRE) -- KNIGHT THERAPEUTICS INC., (TSX: GUD) ("KNIGHT") A PAN-AM...
Více zde
AMNEAL TO REPORT SECOND QUARTER 2025 RESULTS ON AUGUST 5, 2025
09-07-2025
BRIDGEWATER, N.J., JULY 09, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (...
Více zde
AMNEAL HIGHLIGHTS POSITIVE TOPLINE RESULTS FROM CONFIRMATORY CLINICAL STUDY OF BIOSIMILAR CANDIDATE TO XOLAIR(R) (OMALIZUMAB), DEVELOPED BY KASHIV BIOSCIENCES
25-06-2025
AMNEAL HOLDS EXCLUSIVE U.S. COMMERCIALIZATION RIGHTS; BLA FILING EXPECTED IN Q4 2025 POISED TO BE AM...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION
12-06-2025
BRIDGEWATER, N.J., JUNE 12, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (“AMNEAL” OR T...
Více zde
AMNEAL TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES IN JUNE
29-05-2025
BRIDGEWATER, N.J., MAY 29, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) WILL...
Více zde
AMNEAL RECEIVES U.S. FDA APPROVAL FOR BREKIYA® (DIHYDROERGOTAMINE MESYLATE) INJECTION FOR THE ACUTE TREATMENT OF MIGRAINE AND CLUSTER HEADACHES IN ADULTS
15-05-2025
BREKIYA® BECOMES THE FIRST AND ONLY DHE AUTOINJECTOR THAT ALLOWS PATIENTS TO SELF-ADMINISTER THE SA...
Více zde
AMNEAL AND APIJECT TO EXPAND STERILE AND BLOW-FILL-SEAL (BFS) CAPABILITIES FOR ADVANCED PHARMACEUTICAL MANUFACTURING IN THE U.S.
08-05-2025
-ADDS BFS PLATFORM TECHNOLOGY TO PROVIDE LARGE-SCALE PRODUCTION CAPACITY FOR STERILE DRUG DOSAGE FOR...
Více zde
AMNEAL REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
02-05-2025
BRIDGEWATER, N.J.--(BUSINESS WIRE)--AMNEAL REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS....
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-02-03 00:00:00 | 8-K | Stáhnout | |
| 2026-01-28 00:00:00 | 8-K | Stáhnout | |
| 2026-01-13 00:00:00 | 8-K | Stáhnout | |
| 2025-11-06 00:00:00 | 10-Q | Stáhnout | |
| 2025-10-30 00:00:00 | 8-K | Stáhnout | |
| 2025-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2025-08-05 01:00:00 | 8-K | Stáhnout | |
| 2025-08-05 00:00:00 | 8-K | Stáhnout | |
| 2025-08-01 01:00:00 | 8-K | Stáhnout | |
| 2025-08-01 00:00:00 | 8-K | Stáhnout | |
| 2025-07-24 01:00:00 | 8-K | Stáhnout | |
| 2025-07-24 00:00:00 | 8-K | Stáhnout | |
| 2025-07-21 01:00:00 | 8-K | Stáhnout | |
| 2025-07-21 00:00:00 | 8-K | Stáhnout | |
| 2025-05-08 01:00:00 | 8-K | Stáhnout | |
| 2025-05-08 00:00:00 | 8-K | Stáhnout | |
| 2025-05-07 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-07 00:00:00 | 10-Q | Stáhnout | |
| 2025-05-02 01:00:00 | 8-K | Stáhnout | |
| 2025-05-02 00:00:00 | 8-K | Stáhnout | |
| 2025-03-06 00:00:00 | 8-K | Stáhnout | |
| 2025-03-05 23:00:00 | 8-K | Stáhnout | |
| 2025-02-28 00:00:00 | 8-K | Stáhnout | |
| 2025-02-28 00:00:00 | 10-K | Stáhnout | |
| 2025-02-27 23:00:00 | 8-K | Stáhnout | |
| 2025-02-27 23:00:00 | 10-K | Stáhnout | |
| 2025-01-15 00:00:00 | 8-K | Stáhnout | |
| 2025-01-14 23:00:00 | 8-K | Stáhnout | |
| 2024-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-11 23:00:00 | 10-Q | Stáhnout | |
| 2024-11-08 00:00:00 | 8-K | Stáhnout | |
| 2024-11-07 23:00:00 | 8-K | Stáhnout | |
| 2024-10-01 01:00:00 | 8-K | Stáhnout | |
| 2024-10-01 00:00:00 | 8-K | Stáhnout | |
| 2024-08-09 01:00:00 | 8-K | Stáhnout | |
| 2024-08-09 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-09 00:00:00 | 8-K | Stáhnout | |
| 2024-08-09 00:00:00 | 10-Q | Stáhnout | |
| 2024-05-08 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-08 00:00:00 | 10-Q | Stáhnout | |
| 2024-05-07 01:00:00 | 8-K | Stáhnout | |
| 2024-05-07 00:00:00 | 8-K | Stáhnout | |
| 2024-05-03 01:00:00 | 8-K | Stáhnout | |
| 2024-05-03 00:00:00 | 8-K | Stáhnout | |
| 2024-03-14 00:00:00 | 10-K | Stáhnout | |
| 2024-03-13 23:00:00 | 10-K | Stáhnout | |
| 2024-03-01 00:00:00 | 8-K | Stáhnout | |
| 2024-02-29 23:00:00 | 8-K | Stáhnout | |
| 2024-01-10 00:00:00 | 8-K | Stáhnout | |
| 2024-01-09 23:00:00 | 8-K | Stáhnout | |
| 2023-12-15 00:00:00 | 8-K | Stáhnout | |
| 2023-12-14 23:00:00 | 8-K | Stáhnout | |
| 2023-11-14 00:00:00 | 8-K | Stáhnout | |
| 2023-11-13 23:00:00 | 8-K | Stáhnout | |
| 2023-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2023-11-07 00:00:00 | 8-K | Stáhnout | |
| 2023-11-06 23:00:00 | 8-K | Stáhnout | |
| 2023-10-23 01:00:00 | 8-K | Stáhnout | |
| 2023-10-23 00:00:00 | 8-K | Stáhnout | |
| 2023-10-17 01:00:00 | 8-K | Stáhnout | |
| 2023-10-17 00:00:00 | 8-K | Stáhnout | |
| 2023-08-08 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-08 00:00:00 | 10-Q | Stáhnout | |
| 2023-08-04 01:00:00 | 8-K | Stáhnout | |
| 2023-08-04 00:00:00 | 8-K | Stáhnout | |
| 2023-05-19 01:00:00 | 8-K | Stáhnout | |
| 2023-05-19 00:00:00 | 8-K | Stáhnout | |
| 2023-05-12 01:00:00 | 8-K | Stáhnout | |
| 2023-05-12 00:00:00 | 8-K | Stáhnout | |
| 2023-05-09 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-09 00:00:00 | 10-Q | Stáhnout | |
| 2023-05-05 01:00:00 | 8-K | Stáhnout | |
| 2023-05-05 00:00:00 | 8-K | Stáhnout | |
| 2023-04-17 01:00:00 | 8-K | Stáhnout | |
| 2023-04-17 00:00:00 | 8-K | Stáhnout | |
| 2023-03-03 00:00:00 | 10-K | Stáhnout | |
| 2023-03-02 23:00:00 | 10-K | Stáhnout | |
| 2023-03-02 00:00:00 | 8-K | Stáhnout | |
| 2023-03-01 23:00:00 | 8-K | Stáhnout | |
| 2023-01-10 00:00:00 | 8-K | Stáhnout | |
| 2023-01-09 23:00:00 | 8-K | Stáhnout | |
| 2022-11-07 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-06 23:00:00 | 10-Q | Stáhnout | |
| 2022-11-04 00:00:00 | 8-K | Stáhnout | |
| 2022-11-03 23:00:00 | 8-K | Stáhnout | |
| 2022-09-06 01:00:00 | 8-K | Stáhnout | |
| 2022-09-06 00:00:00 | 8-K | Stáhnout | |
| 2022-08-08 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-08 00:00:00 | 10-Q | Stáhnout | |
| 2022-08-05 01:00:00 | 8-K | Stáhnout | |
| 2022-08-05 00:00:00 | 8-K | Stáhnout | |
| 2022-08-03 01:00:00 | 8-K | Stáhnout | |
| 2022-08-03 00:00:00 | 8-K | Stáhnout | |
| 2022-07-19 01:00:00 | 8-K | Stáhnout | |
| 2022-07-19 00:00:00 | 8-K | Stáhnout | |
| 2022-06-02 01:00:00 | 8-K | Stáhnout | |
| 2022-06-02 00:00:00 | 8-K | Stáhnout | |
| 2022-05-13 01:00:00 | 8-K | Stáhnout | |
| 2022-05-13 00:00:00 | 8-K | Stáhnout | |
| 2022-05-06 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-06 00:00:00 | 10-Q | Stáhnout | |
| 2022-05-04 01:00:00 | 8-K | Stáhnout | |
| 2022-05-04 00:00:00 | 8-K | Stáhnout | |
| 2022-03-16 00:00:00 | 8-K | Stáhnout | |
| 2022-03-15 23:00:00 | 8-K | Stáhnout | |
| 2022-03-02 00:00:00 | 8-K | Stáhnout | |
| 2022-03-01 23:00:00 | 8-K | Stáhnout | |
| 2022-03-01 00:00:00 | 10-K | Stáhnout | |
| 2022-02-28 23:00:00 | 10-K | Stáhnout | |
| 2022-01-11 00:00:00 | 8-K | Stáhnout | |
| 2022-01-10 23:00:00 | 8-K | Stáhnout | |
| 2022-01-05 00:00:00 | 8-K | Stáhnout | |
| 2022-01-04 23:00:00 | 8-K | Stáhnout | |
| 2021-11-08 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-07 23:00:00 | 10-Q | Stáhnout | |
| 2021-11-03 00:00:00 | 8-K | Stáhnout | |
| 2021-11-02 23:00:00 | 8-K | Stáhnout | |
| 2021-08-09 01:00:00 | 8-K | Stáhnout | |
| 2021-08-09 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-09 00:00:00 | 8-K | Stáhnout | |
| 2021-08-09 00:00:00 | 10-Q | Stáhnout | |
| 2021-05-10 01:00:00 | 8-K | Stáhnout | |
| 2021-05-10 00:00:00 | 8-K | Stáhnout | |
| 2021-05-07 01:00:00 | 8-K | Stáhnout | |
| 2021-05-07 01:00:00 | 10-Q | Stáhnout | |
| 2021-05-07 00:00:00 | 8-K | Stáhnout | |
| 2021-05-07 00:00:00 | 10-Q | Stáhnout | |
| 2021-04-05 01:00:00 | 8-K | Stáhnout | |
| 2021-04-05 00:00:00 | 8-K | Stáhnout | |
| 2021-03-01 00:00:00 | 10-K | Stáhnout | |
| 2021-02-28 23:00:00 | 10-K | Stáhnout | |
| 2021-02-26 00:00:00 | 8-K | Stáhnout | |
| 2021-02-25 23:00:00 | 8-K | Stáhnout | |
| 2021-02-16 00:00:00 | 8-K | Stáhnout | |
| 2021-02-15 23:00:00 | 8-K | Stáhnout | |
| 2021-01-12 00:00:00 | 8-K | Stáhnout | |
| 2021-01-11 23:00:00 | 8-K | Stáhnout | |
| 2020-12-18 00:00:00 | 8-K | Stáhnout | |
| 2020-12-17 23:00:00 | 8-K | Stáhnout | |
| 2020-11-06 00:00:00 | 8-K | Stáhnout | |
| 2020-11-06 00:00:00 | 10-Q | Stáhnout | |
| 2020-11-05 23:00:00 | 8-K | Stáhnout | |
| 2020-11-05 23:00:00 | 10-Q | Stáhnout | |
| 2020-08-06 01:00:00 | 8-K | Stáhnout | |
| 2020-08-06 01:00:00 | 10-Q | Stáhnout | |
| 2020-08-06 00:00:00 | 8-K | Stáhnout | |
| 2020-08-06 00:00:00 | 10-Q | Stáhnout | |
| 2020-08-04 01:00:00 | 8-K | Stáhnout | |
| 2020-08-04 00:00:00 | 8-K | Stáhnout | |
| 2020-05-11 01:00:00 | 8-K | Stáhnout | |
| 2020-05-11 01:00:00 | 10-Q | Stáhnout | |
| 2020-05-11 00:00:00 | 8-K | Stáhnout | |
| 2020-05-11 00:00:00 | 10-Q | Stáhnout | |
| 2020-05-08 01:00:00 | 8-K | Stáhnout | |
| 2020-05-08 00:00:00 | 8-K | Stáhnout | |
| 2020-03-12 00:00:00 | 8-K | Stáhnout | |
| 2020-03-11 23:00:00 | 8-K | Stáhnout | |
| 2020-03-02 00:00:00 | 10-K | Stáhnout | |
| 2020-03-01 23:00:00 | 10-K | Stáhnout | |
| 2020-02-26 00:00:00 | 8-K | Stáhnout | |
| 2020-02-25 23:00:00 | 8-K | Stáhnout | |
| 2020-02-04 00:00:00 | 8-K | Stáhnout | |
| 2020-02-03 23:00:00 | 8-K | Stáhnout | |
| 2020-01-15 00:00:00 | 8-K | Stáhnout | |
| 2020-01-14 23:00:00 | 8-K | Stáhnout | |
| 2019-12-16 00:00:00 | 8-K | Stáhnout | |
| 2019-12-15 23:00:00 | 8-K | Stáhnout | |
| 2019-12-10 00:00:00 | 8-K | Stáhnout | |
| 2019-12-09 23:00:00 | 8-K | Stáhnout | |
| 2019-11-07 00:00:00 | 10-Q | Stáhnout | |
| 2019-11-06 23:00:00 | 10-Q | Stáhnout | |
| 2019-11-06 00:00:00 | 8-K | Stáhnout | |
| 2019-11-05 23:00:00 | 8-K | Stáhnout | |
| 2019-10-11 01:00:00 | 8-K | Stáhnout | |
| 2019-10-11 00:00:00 | 8-K | Stáhnout | |
| 2019-08-05 01:00:00 | 8-K | Stáhnout | |
| 2019-08-05 01:00:00 | 10-Q | Stáhnout | |
| 2019-08-05 00:00:00 | 8-K | Stáhnout | |
| 2019-08-05 00:00:00 | 10-Q | Stáhnout | |
| 2019-07-10 01:00:00 | 8-K | Stáhnout | |
| 2019-07-10 00:00:00 | 8-K | Stáhnout | |
| 2019-05-09 01:00:00 | 8-K | Stáhnout | |
| 2019-05-09 01:00:00 | 10-Q | Stáhnout | |
| 2019-05-09 00:00:00 | 8-K | Stáhnout | |
| 2019-05-09 00:00:00 | 10-Q | Stáhnout | |
| 2019-03-01 00:00:00 | 10-K | Stáhnout | |
| 2019-02-28 23:00:00 | 10-K | Stáhnout | |
| 2019-02-28 00:00:00 | 8-K | Stáhnout | |
| 2019-02-27 23:00:00 | 8-K | Stáhnout | |
| 2019-01-24 00:00:00 | 8-K | Stáhnout | |
| 2019-01-23 23:00:00 | 8-K | Stáhnout | |
| 2019-01-08 00:00:00 | 8-K | Stáhnout | |
| 2019-01-07 23:00:00 | 8-K | Stáhnout | |
| 2019-01-07 00:00:00 | 8-K | Stáhnout | |
| 2019-01-06 23:00:00 | 8-K | Stáhnout | |
| 2018-12-07 00:00:00 | 8-K | Stáhnout | |
| 2018-12-06 23:00:00 | 8-K | Stáhnout | |
| 2018-11-07 00:00:00 | 8-K | Stáhnout | |
| 2018-11-07 00:00:00 | 10-Q | Stáhnout | |
| 2018-11-06 23:00:00 | 8-K | Stáhnout | |
| 2018-11-06 23:00:00 | 10-Q | Stáhnout | |
| 2018-08-09 01:00:00 | 8-K | Stáhnout | |
| 2018-08-09 01:00:00 | 10-Q | Stáhnout | |
| 2018-08-09 00:00:00 | 8-K | Stáhnout | |
| 2018-08-09 00:00:00 | 10-Q | Stáhnout | |
| 2018-06-07 01:00:00 | 8-K | Stáhnout | |
| 2018-06-07 00:00:00 | 8-K | Stáhnout | |
| 2018-05-21 01:00:00 | 8-K | Stáhnout | |
| 2018-05-21 00:00:00 | 8-K | Stáhnout | |
| 2018-05-16 01:00:00 | 8-K | Stáhnout | |
| 2018-05-16 00:00:00 | 8-K | Stáhnout | |
| 2018-05-15 01:00:00 | 10-Q | Stáhnout | |
| 2018-05-15 00:00:00 | 10-Q | Stáhnout | |
| 2018-05-07 01:00:00 | 8-K | Stáhnout | |
| 2018-05-07 00:00:00 | 8-K | Stáhnout | |
| 2018-03-09 00:00:00 | 10-K | Stáhnout | |
| 2018-03-08 23:00:00 | 10-K | Stáhnout |
